An exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas.

Tran, Duy Cong

An exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas. [electronic resource] - Journal of the American Academy of Dermatology 05 2018 - 1011-1013.e3 p. digital

Publication Type: Journal Article

1097-6787

10.1016/j.jaad.2017.11.031 doi


Aged
Aged, 80 and over
Aminopyridines--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biphenyl Compounds--administration & dosage
Carcinoma, Basal Cell--drug therapy
Cohort Studies
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Maximum Tolerated Dose
Middle Aged
Morpholines--administration & dosage
Neoplasm Invasiveness--pathology
Neoplasm Staging
Prognosis
Prospective Studies
Pyridines--administration & dosage
Skin Neoplasms--drug therapy
Survival Analysis
Treatment Outcome